Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avita Medical Inc (RCEL)

Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Shares of Avita Medical Are Down Monday

The company's potential launch of a new device will likely be pushed back.

AVH.AX : 4.950 (+0.61%)
RCEL : 16.50 (+3.19%)
Why Shares of Avita Medical Are Soaring Thursday

The company's lead product gained a big indication approval from the FDA.

AVH.AX : 4.950 (+0.61%)
RCEL : 16.50 (+3.19%)
Here's Why Momentum in Avita Medical Inc. (RCEL) Should Keep going

Avita Medical Inc. (RCEL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through...

RCEL : 16.50 (+3.19%)
Indaptus (INDP) Surges on Upbeat Pre-Clinical Decoy Data

Indaptus (INDP) announces positive pre-clinical efficacy data from a poster presentation made at a scientific conference from its proprietary Decoy platform pre-clinical study. Stock is up 22%.

RCEL : 16.50 (+3.19%)
INDP : 2.49 (-11.07%)
BTTX : 0.0129 (-5.84%)
EQRX : 2.34 (-2.09%)
What Makes Avita Medical Inc. (RCEL) a Strong Momentum Stock: Buy Now?

Does Avita Medical Inc. (RCEL) have what it takes to be a top stock pick for momentum investors? Let's find out.

RCEL : 16.50 (+3.19%)
Novo Nordisk (NVO) Increases Sales & Operating Profit Guidance

Novo Nordisk (NVO) increases annual guidance for the year 2023 on higher sales expectations for Ozempic and Wegovy.

NVO : 128.05 (-1.05%)
INVA : 15.29 (+2.07%)
RCEL : 16.50 (+3.19%)
EQRX : 2.34 (-2.09%)
Novo (NVO) & Aspect Biosystems Unite to Develop Tissue Therapy

Pharma Goliath Novo Nordisk (NVO) inks collaboration agreement with Aspect Biosystems to develop and commercialize transformative cell therapy treatments for type I diabetes patients.

NVO : 128.05 (-1.05%)
INVA : 15.29 (+2.07%)
RCEL : 16.50 (+3.19%)
EQRX : 2.34 (-2.09%)
Aurinia (AUPH) Up 11% on Issue of New Additional Lupkynis Patent

Aurinia Pharmaceuticals (AUPH) announces the issue of its new and refined method-of-use patent, supplementing its existing patent, for Lupkynis to treat lupus nephritis. Shares are up 11%.

AUPH : 5.00 (+1.42%)
RCEL : 16.50 (+3.19%)
BTTX : 0.0129 (-5.84%)
EQRX : 2.34 (-2.09%)
Here's What Could Help Avita Medical Inc. (RCEL) Maintain Its Recent Price Strength

Avita Medical Inc. (RCEL) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

RCEL : 16.50 (+3.19%)
Pacira's (PCRX) sNDA for Exparel Accepted for FDA Review

The FDA accepts Pacira's (PCRX) sNDA filing, which seeks to expand the label of its pain drug Exparel to include both sciatic and femoral nerve blocks. A final decision is expected by November 2023.

PCRX : 29.04 (+1.86%)
RCEL : 16.50 (+3.19%)
AVTX : 4.75 (+2.72%)
EQRX : 2.34 (-2.09%)

Barchart Exclusives

IonQ vs. D-Wave: Which Quantum Computing Stock Has More Upside Potential?
In the growing quantum computing market, analysts expect IONQ stock to deliver significantly higher upside than QBTS. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar